These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 30039543

  • 1. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
    De Luca L, Arca M, Temporelli PL, Colivicchi F, Gonzini L, Lucci D, Bosco B, Callerame M, Lettica GV, Di Lenarda A, Gulizia MM, START Investigators.
    Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
    [Abstract] [Full Text] [Related]

  • 2. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up.
    Auckle R, Su B, Li H, Xu S, Xie M, Song Y, Abdul Quddus M, Xu Y, Liu B, Che W.
    PLoS One; 2017 Aug; 12(10):e0186815. PubMed ID: 29088271
    [Abstract] [Full Text] [Related]

  • 3. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H, Wang H, Liu P, Wang X, Zhu W, Jiang W, Hu X, Deng J.
    BMC Cardiovasc Disord; 2024 Mar 05; 24(1):144. PubMed ID: 38443803
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
    Faggiano P, Pirillo A, Griffo R, Ambrosetti M, Pedretti R, Scorcu G, Werren M, Febo O, Malfatto G, Favretto G, Sarullo F, Antonini-Canterin F, Zobbi G, Temporelli P, Catapano AL, Centro Studi e Formazione - Italian Association for Cardiovascular Prevention and Rehabilitation.
    Int J Cardiol; 2018 Feb 01; 252():193-198. PubMed ID: 29249427
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease.
    Nawaka N, Rattanawan C, Pussadhamma B, Wutthimanop A, Nuinoon M, Porntadavity S, Theansun W, Jeenduang N.
    Postgrad Med; 2023 May 01; 135(4):410-417. PubMed ID: 36803651
    [Abstract] [Full Text] [Related]

  • 7. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM, Maggioni AP, Abrignani MG, Bilato C, Mangiacapra F, Sanchez FA, Piovaccari G, Montagna L, Marini M, De Biasio M, Averna M, Casula M, Colivicchi F, Fabbri G, Lucci D, Zampoleri V, Catapano AL, POSTER Investigators.
    Atherosclerosis; 2020 Sep 01; 308():32-38. PubMed ID: 32823190
    [Abstract] [Full Text] [Related]

  • 8. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.
    Farnier M, Salignon-Vernay C, Yao H, Chague F, Brunel P, Maza M, Brunet D, Bichat F, Beer JC, Cottin Y, Zeller M.
    J Clin Lipidol; 2019 Sep 01; 13(4):601-607. PubMed ID: 31324593
    [Abstract] [Full Text] [Related]

  • 9. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
    Korneva V, Kuznetsova T, Julius U.
    Atheroscler Suppl; 2019 Dec 01; 40():79-87. PubMed ID: 31818452
    [Abstract] [Full Text] [Related]

  • 10. Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia.
    Yaman S, Ozdemir D, Akman BT, Cakir B, Ersoy O.
    Postgrad Med; 2021 Mar 01; 133(2):146-153. PubMed ID: 32744105
    [Abstract] [Full Text] [Related]

  • 11. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
    Latkovskis G, Saripo V, Gilis D, Nesterovics G, Upena-Roze A, Erglis A.
    Atherosclerosis; 2018 Oct 01; 277():347-354. PubMed ID: 30270070
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Yamashita S, Masuda D, Harada-Shiba M, Arai H, Bujo H, Ishibashi S, Daida H, Koga N, Oikawa S.
    J Atheroscler Thromb; 2022 May 01; 29(5):608-638. PubMed ID: 33980760
    [Abstract] [Full Text] [Related]

  • 13. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
    Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG.
    J Clin Endocrinol Metab; 2012 Nov 01; 97(11):3956-64. PubMed ID: 22893714
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
    Vlad CE, Foia L, Florea L, Costache II, Covic A, Popescu R, Reurean-Pintilei D, Covic A.
    Lipids Health Dis; 2021 Jan 11; 20(1):4. PubMed ID: 33430859
    [Abstract] [Full Text] [Related]

  • 15. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB, Kulenovic I, Klausen IC, Falk E.
    J Clin Lipidol; 2016 Jan 11; 10(5):1145-1152.e1. PubMed ID: 27678431
    [Abstract] [Full Text] [Related]

  • 16. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A, Castillo S, Gonzalez-Vioque E, Dominguez F, Quintana L, Lluís-Ganella C, Escudier JM, Ortega J, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P.
    J Am Coll Cardiol; 2017 Oct 03; 70(14):1732-1740. PubMed ID: 28958330
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study.
    Casula M, Olmastroni E, Pirillo A, Catapano AL, MEMBERS OF THE LIPIGEN STEERING COMMETTEE, PRINCIPAL INVESTIGATORS: Coordinator center, Participant Centers, Participant Laboratories, COLLABORATORS, STUDY CENTRAL LABORATORY AND ANALYSIS GROUP.
    Atherosclerosis; 2018 Oct 03; 277():413-418. PubMed ID: 30270079
    [Abstract] [Full Text] [Related]

  • 18. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S, Wu NQ, Zhu CG, Zhang Y, Guo YL, Gao Y, Li XL, Qing P, Cui CJ, Xu RX, Sun J, Liu G, Dong Q, Li JJ.
    Atherosclerosis; 2017 May 03; 260():67-74. PubMed ID: 28351002
    [Abstract] [Full Text] [Related]

  • 19. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
    Vikulova DN, Trinder M, Mancini GBJ, Pimstone SN, Brunham LR.
    Can J Cardiol; 2021 Nov 03; 37(11):1733-1742. PubMed ID: 34455025
    [Abstract] [Full Text] [Related]

  • 20. Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity.
    Pojskic L, Pojskic B.
    Atherosclerosis; 2018 Oct 03; 277():278-281. PubMed ID: 30270059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.